NIH is ending billions of dollars in foreign subawards, jeopardizing thousands of projects on infectious diseases, cancer and more.
Unless foreign researchers secure funding directly from NIH by October — a tall order for any researcher — clinical trials abroad and other research will shut down.
Move by US biomedical agency jeopardizes thousands of projects on infectious diseases, cancer and more.
